Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial.
about
Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.Evidence based guidelines for complex regional pain syndrome type 1Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedureGabapentin for chronic neuropathic pain and fibromyalgia in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsGabapentin for acute and chronic painGabapentin for acute and chronic painAn evidence-based algorithm for the treatment of neuropathic painRandomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigationAnti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppressionDifferences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentinThe effectiveness of anticonvulsants in psychiatric disordersUpdate on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options.A preliminary report on stem cell therapy for neuropathic pain in humans.Pharmacologic therapies for complex regional pain syndrome.The effectiveness and cost evaluation of pain exposure physical therapy and conventional therapy in patients with complex regional pain syndrome type 1. Rationale and design of a randomized controlled trial.Gabapentin reverses central hypersensitivity and suppresses medial prefrontal cortical glucose metabolism in rats with neuropathic pain.Gabapentin for chronic neuropathic pain in adults.EFNS guidelines on pharmacological treatment of neuropathic pain.Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injuryPreventing Chronic Pain following Acute Pain: Risk Factors, Preventive Strategies, and their Efficacy.Gabapentin in the treatment of neuropathic pain.Pharmacologic management part 2: lesser-studied neuropathic pain diseases.Pharmacological strategies in relieving neuropathic pain.The Efficacy of Gabapentin in Patients with Central Post-stroke PainNew medication treatment options for bipolar disorders.'Protective premedication': an option with gabapentin and related drugs? A review of gabapentin and pregabalin in in the treatment of post-operative pain.The nursing role in recognizing and assessing neuropathic pain.Symptomatic and palliative care for stroke survivorsSystemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model.Effect of photobiomodulation therapy (808 nm) in the control of neuropathic pain in mice.Clinical management of pain in advanced lung cancer.The pharmacotherapy of chronic pain: a review.Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice.Postoperative pain management: new, convenient analgesic therapies.Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec databaseEnriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review.
P2860
Q21144723-E29D1418-67F4-4F05-8960-231260FD79B1Q21261406-3243D9D7-F3F5-4886-A9C8-B28BEFC5F3FBQ21261955-EAB52E20-DB66-4854-8031-AA85A74E0100Q24194998-891E5F48-55D3-419A-BA83-B04BC679EA16Q24235709-A1726FB0-7020-4F36-9613-6B4ACF9F92EEQ24235992-64EB89BB-0789-49DC-9E20-8B9205A92364Q24246411-938D06E0-B10A-4A4B-A7AB-2DED3E876209Q24680820-3FB3C167-9BCB-4D87-9DEA-2DA51CB764D7Q24802765-5699E683-A595-4CCC-A704-E52A2F7552C2Q27498844-EC6730B7-ABA6-4946-9E2D-E5DF19E5DBF5Q28468568-0614F8A9-7CF9-46A5-9F05-89ED188B4B10Q28485343-9301A6A8-6E4B-4246-AA65-9ECA3B267F7DQ28744504-28292738-B0C9-4F35-9776-5B136FE478D3Q30391958-DB24EB9C-4F1D-4018-9D0A-DBA9BBC522E9Q33610446-004437F8-93C4-4ABE-A504-F383F9E11766Q34038997-A30D92F4-9B43-4666-8B70-408B42E597D9Q34239287-035CC4B5-1F4B-4DB9-8E79-8FB9A52A8607Q34278619-1585316E-7B97-49F2-918D-0DDBC4B79156Q34557703-561F5748-0CFB-4557-B4C5-5F7DD79DB8C4Q34573607-B66DA632-A4C8-4F68-8A2B-C93EA963375BQ34595383-23AC615A-2F23-40F4-95FC-9AD6FFFA3352Q34617315-CEEAE108-943A-490B-A007-62167A010A69Q35046026-4C39D9C3-8280-4F11-B099-C52CECAFC9C3Q35553149-B254B5F9-7020-41F1-B126-79B84E9BEACCQ35674900-08BA8A26-6A3E-461E-A930-ED87144820CBQ35680406-E6D6CF0F-2E82-4B3E-8B87-5CC408EBC0E4Q35784044-CEAC52A3-7BE1-4461-ABF6-76EF563AA00EQ35843307-F7CC3C72-7BC5-46A3-A29D-1C0AB72348C0Q35872066-A39FC4CD-A696-4FD8-BF38-C1347E638CBFQ35880441-1D682B6A-CF55-4AA0-9B95-9FBD681F924BQ35963976-DF4CC263-73AA-4899-93B3-4C30B512336AQ36044103-92DCEE79-7E49-4655-A80F-2DBB38A64AA2Q36087104-F5A657C0-C2B9-499C-BBFD-6A1C5E2832C2Q36304970-C25E1ADE-08A4-438F-B98C-401E53C97826Q36327481-6E71C8D1-5DC0-44EB-8143-FF32B5D44513Q36411163-A503EC22-82EE-41EB-85D3-3C65C9A71F5EQ36638304-8F8B1ED6-28AB-4992-9793-68268AC54A83Q36739779-D4308B86-A4ED-4F0F-812E-C4125A3EE33BQ36764490-9B8E6D25-E42D-48A9-B4C7-919CD635FFDFQ36803417-346E3B43-471F-4094-83C5-79E0A6AA4E09
P2860
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@en
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@nl
type
label
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@en
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@nl
prefLabel
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@en
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@nl
P921
P1433
P1476
Gabapentin in neuropathic pain ...... ind, placebo-controlled trial.
@en
P2093
M G Serpell
Neuropathic pain study group
P304
P356
10.1016/S0304-3959(02)00255-5
P407
P577
2002-10-01T00:00:00Z